The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
Ashton TM, Fokas E, Kunz-Schughart LA, Folkes LK, Anbalagan S, Huether M, Kelly CJ, Pirovano G, Buffa FM, Hammond EM, Stratford M, Muschel RJ, Higgins GS, McKenna WG.
Ashton TM, et al. Among authors: higgins gs.
Nat Commun. 2016 Jul 25;7:12308. doi: 10.1038/ncomms12308.
Nat Commun. 2016.
PMID: 27453292
Free PMC article.